Epico

EIPICO (Egyptian International Pharmaceutical Industries Co.) is the leading pharmaceutical manufacturer in Egypt and a dominant player in the Middle East and North Africa (MENA) region. The company produces an extensive portfolio of over 400 products across various therapeutic areas, including antibiotics, ophthalmics, and chronic disease treatments. EIPICO is currently undergoing a major strategic expansion into the biosimilars market with the development of EIPICO 3, a state-of-the-art facility dedicated to the production of biological products and biosimilars. As a significant exporter, the company supplies medicines to over 65 countries worldwide and maintains long-standing manufacturing partnerships with global pharmaceutical leaders. Its operations are characterized by high-volume GMP manufacturing and a growing focus on high-tech biological therapies.